Stay updated with breaking news from Rd Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, today announced it has...
/PRNewswire/ -- The regenerative medicine company Seraxis today announces that Shelley Hartman, Jerry Baty, and Min-Jung Choi are appointed to its Board of...
Veralox Therapeutics, a Frederick, Md.-based biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, closed a $16.6m Series A financing. The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous investors Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO. In conjunction with the funding, Ben Scruggs, PhD, principal at Hatteras V...
May 18, 2021 7:00am Vedere's first indication will be retinitis pigmentosa, a group of rare genetic disorders that damages the light-sensing cells lining the back of the eye, said CEO Cyrus Mozayeni, M.D. (Pixabay) Cyrus Mozayeni, M.D. (Courtesy Vedere Bio II) Cyrus Mozayeni’s first go at vision-restoring gene therapies got snapped up as it was just getting started. Lots of suitors came knocking even when the company, Vedere Bio, was working under the radar, and Novartis eventually ponied up $150 million upfront to buy it, with a promise of $130 million more. Now, Mozayeni and hi...
The Future of Worker Financial Security: The Nexus of Work and Benefits Event information Location In the United States, a dominant narrative that having a job equals financial security persists, yet the majority of workers in America have jobs that do not allow them to achieve financial security. In fact, many workers lack benefits, have low earnings, and live in poverty. The type of job matters: workers with full-time, permanent positions and more robust packages of benefits do better than those without access to those options. In a new report developed together with its ,...